Abstracts

Immunologic Pathways That Predict Mortality in HIV+ Ugandans Initiating ART

Background: Abnormal immune activation persists in most HIV-infected individuals despite prolonged antiretroviral therapy (ART)-mediated viral suppression, and predicts increased morbidity and mortality, but the specific immunologic pathways predicting disease remain incompletely defined, particularly in resource-limited settings. Plasma kynurenine/tryptophan (KT) ratio, a marker of indoleamine 2,3-dioxygenase-1 (IDO) activity, strongly predicts mortality in this setting, but whether…

Immune Activation Impairs Yellow Fever Vaccine Efficacy in HIV-Infected Patients

Background: While highly immunogenic in healthy vaccinees, Yellow Fever vaccine (YFV) induces weaker and less durable immune responses in HIV-infected individuals. Chronic immune activation may impair cellular and humoral responses to YFV in HIV-uninfected individuals, but little is known about the immunologic predictors of YFV response in HIV infection. We enrolled HIV-infected and –uninfected adults…

Association Between sCD163 and CMV IgG in Virologically Suppressed HIV+ Patients

Background: HIV+ patients with controlled viremia have ongoing chronic inflammation which has been associated with an increased risk for cardiovascular and neurocognitive disease. Cytomegalovirus (CMV) has been implicated as a potential driver of this inflammation. Soluble CD163 (sCD163) is a marker of monocyte/macrophage activation and is upregulated in inflammatory states. We explore the relationship between…

The mTORC1 Inhibitors, Temsirolimus and Everolimus, Suppress HIV Patient-Derived CD4+ T-Cell Death and Activation In Vitro

Background: Activated T cells support their energetic and biosynthetic demands in part by increasing glucose uptake and glycolysis. Glucose transporter 1 (Glut1), the major glucose transporter on T cells, is essential for CD4+ T cell activation and effector functions, and its expression is increased on CD4+ T cells in HIV-infected subjects. High Glut1 expression on…

Decreased Monocyte Activation With Daily Acyclovir Use in HIV-1/HSV-2 Coinfected Women

Background: In two separate randomized control trials, acyclovir treatment of HSV-2/HIV coinfected individuals significantly reduced HIV viral load, and decreased the rate of disease progression. It is unclear if the protective effect of acyclovir use on HIV disease is a direct effect of decreasing HIV replication, or a secondary effect of decreased immune activation associated…

Atorvastatin Reduced T-Cell Activation and Exhaustion Among Suboptimal Immune Responders: A Randomized Crossover Placebo Controlled Trial

Background: T-cell activation independently predicts mortality, poor immune recovery and non-AIDS illnesses during combination antiretroviral therapy (cART). Atorvastatin showed anti-immune activation effects among HIV-infected cART-naïve individuals. We hypothesized that adjunct atorvastatin therapy would reduce T-cell activation among cART-treated adults with suboptimal immune recovery. Methods: A randomized double-blind placebo controlled cross-over trial, of atorvastatin 80 mg…

P2X Type Purinergic Antagonists Can Block HIV-1 Infection and Associated Inflammation

Background: HIV-1 causes a chronic, incurable infection that is associated with chronic inflammation. Even in the face of virologic suppression with antiretroviral therapy this inflammation can persist. The mechanism of this inflammation is not clearly understood. Purinergic receptors are known to be mediators of inflammatory responses and can contribute to pro-inflammatory cytokine production and lymphocyte…

CD4+ T cell death mediated by pyroptosis in early SIV infected lymphatic tissues

Background: Lymphatic tissues are the principle sites for HIV-1 replication, host-virus interaction and CD4+ T cell loss. However, the current understanding of the virus-host molecular interaction in lymphatic tissues, especially in early infection, is limited. We thus investigated virus-host interaction in the lymph nodes (LNs) of rhesus macaques during early simian immunodeficiency virus (SIV) infection.…

Fibrosis in Lymphoid Tissue Is Associated With Peripheral Blood Regulatory T Cells

Background: HIV may damage the structure in lymphoid tissue replacing the functional space with collagen. Regulatory T cells (Tregs) have anti-inflammatory properties exerting their function in part by secretion of transforming growth factor beta (TGF-b) which is known to induce fibrosis. In pathogenic SIV infection tissue fibrosis induced by TGF-b1-postive Tregs has been demonstrated. Thus,…

Decreased TFR/TFH Ratio in SIV-Infected Rhesus Macaques

Background: T follicular helper cells (TFH) are critical for the development and maintenance of germinal centers (GC) and the humoral immune response. During chronic stages of HIV/SIV infection TFH cells accumulate, possibly as a result of antigenic persistence. The SIV/HIV-associated TFH expansion may also reflect a lack of regulation by suppressive follicular regulatory CD4+ T…